Trial intelligence / Profile preview

Myocardial protection solutions in pediatric congenital heart surgery

RBR-9wqbx9Completed

Sponsor
Hospital de Messejana
Start
Nov 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Open-label trial of HTK Custodiol in Cardiovascular Malformation (CVM) (2 arms), sponsored by Hospital de Messejana. Started Nov 2012; status: completed.

02

Drugs

HTK Custodiol
03

Conditions

Cardiovascular Malformation (CVM)

Beyond the preview

Go deeper on RBR-9wqbx9.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on RBR-9wqbx9.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call